Imaging brain structure and function in schizophrenia: New techniques encounter old problems

Neuroimaging in Psychiatry

Volumn , Issue , 2003, Pages 225-255

  Honey, Rebekah A E ^a   Friston, Karl J ^b   Fletcher, Paul C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25844478829     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203508343-8     Document Type: Chapter

References (114)

1. Buchsbaum MS, Ingvar DH, Kessler R et al. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 1982; 39: 251-9.
2. Ariel RN, Golden CJ, Berg RA et al. Regional cerebral blood flow in schizophrenics. Tests using the xenon Xe 133 inhalation method. Arch Gen Psychiatry 1983; 40: 258-63.
3. Wolkin A, Angrist B, Wolf A et al. Low frontal glucose utilization in chronic schizophrenia: a replication study. Am J Psychiatry 1988; 145: 251-3.
4. Paulman RG, Devous Sr MD, Gregory RR et al. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuro-psychological assessment of schizophrenic brain function. Biol Psychiatry 1990; 27: 377-99.
5. Andreasen NC, O’Leary DS, Flaum M et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 1997; 349: 1730-4.
6. Sheppard G, Gruzelier J, Manchanda R et al. 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet 1983; 2: 1448-52.
7. Gur RE, Resnick SM, Alavi A et al. Regional brain function in schizophrenia. I. A positron emission tomography study. Arch Gen Psychiatry 1987; 44: 119-25.
8. Gur RE, Gur RC, Skolnick BE et al. Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics. Arch Gen Psychiatry 1985; 42: 329-34.
9. Gur RE, Skolnick BE, Gur RC et al. Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry 1983; 40: 1250-4.
10. Early TS, Reiman EM, Raichle ME, Spitznagel EL. Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc Natl Acad Sci USA 1987; 84: 561-3.
11. Cleghorn JM, Garnett ES, Nahmias C et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Res 1989; 28: 119-33.
12. Johnstone EC, Crow TJ, Frith CD et al. Cerebral ventricular size and cognitive impairment in chronic schizophrenics. Lancet 1976; 2: 924-6.
13. Chua SE, McKenna PJ. Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br J Psych 1995; 166: 563-82.
14. Wright IC, Rabe-Hesketh S, Woodruff PWR et al. Regional brain structure in schizophrenia: a meta-analysis of volumetric MRI studies. Am J Psychiatry 2000; 157: 16-25.
15. Andreasen NC. Pieces of the schizophrenia puzzle fall into place. Neuron 1996; 16: 697-700.
16. McCarley RW, Wible CG, Frumin M et al. MRI anatomy of schizophrenia. Biol Psychiatry 1999; 45: 1099-119.
17. Baare WFC, van Oel CJ, Hulshoff HE et al. Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry 2001; 58: 33-40.
18. McNeil TF, Cantor-Graae E, Weinberger DR. Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiatry 2000; 157: 203-12.
19. Ohara K, Xu HD, Matsunaga T et al. Cerebral ventricle-brain ratio in monozygotic twins discordant and concordant for schizophrenia. Prog Neuropsychopharmac Biol Psychiatry 1998; 22: 1043-50.
20. Fannon D, Tennakoon L, Sumich A et al. Third ventricle enlargement and developmental delay in first-episode psychosis: preliminary findings. Br J Psychiatry 2000; 177: 354-9.
21. Matsumoto H, Simmons A, Williams S, Pipe R, Murray R, Frangou S. Structural magnetic imaging of the hippocampus in early onset schizophrenia. Biol Psychiatry 2001; 49: 824-31.
22. Matsumoto H, Simmons A, Williams S et al. Superior temporal gyrus abnormalities in early-onset schizophrenia: similarities and differences with adult-onset schizophrenia. Am J Psychiatry 2001; 158: 1299-304.
23. Suzuki M, Nohara S, Hagino H et al. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophrenia Res 2002; 55: 41-54.
24. McKenna PJ, Tamlyn D, Lund CE, Mortimer AM, Hammond S, Baddeley AD. Amnesic syndrome in schizophrenia. Psychol Med 1990; 20: 967-72.
25. Tamlyn D, McKenna PJ, Mortimer AM, Lund CE, Hammond S, Baddeley AD. Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character. Psychol Med 1992; 22: 101-15.
26. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998; 55: 433-40.
27. Mahurin RK, Velligan DI, Miller AL. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis. Psychiatry Res 1998; 79: 139-49.
28. Morice R, Delahunty A. Frontal/executive impairments in schizophrenia. Schizophrenia Bull 1996; 22: 125-37.
29. McGrath J, Scheldt S, Welham J, Clair A. Performance on tests sensitive to impaired executive ability in schizophrenia, mania and well controls: acute and subacute phases. Schizophrenia Res 1997; 26: 127-37.
30. Foong J, Symms MR, Barker GJ et al. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain 2001; 124: 882-92.
31. Sanfilipo M, Lafargue T, Rusinck H et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia. Arch Gen Psychiatry 2000; 57: 471-80.
32. Sigmundsson T, Suckling J, Maier M et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 2001; 158: 234-43.
33. Bigliani V, Pilowsky LS. In vivo neuropharmacology of schizophrenia. Br J Psychiatry 1999; 174: 23-33.
34. Krystal JH, Abi-Dargham A, Laruelle M, Moghaddam B. Pharmacologic models of psychoses. In: (Charney DS, Nestler EJ, Bunney BS, eds) Neurobiology of Mental Illness. (Oxford University Press: New York, 1999) 214-24.
35. Schroder J, Bubeck B, Silvestri S, Demisch S, Sauer H. Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study. Psychiatry Res 1997; 75: 115-23.
36. Tibbo P, Silverstone PH, McEwan AJ, Scott J, Joshua A, Golberg K. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls. J Psychiatry Neurosci 1997; 22: 39-45.
37. Goldsmith SK, Shapiro RM, Joyce JN. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia: a postmortem study. Arch Gen Psychiatry 1997; 54: 649-58.
38. Domyo T, Kurumaji A, Toru M. An increase in [3H]SCH23390 binding in the cerebral cortex of postmortem brains of chronic schizophrenics. J Neural Trans 2001; 108: 1475-84.
39. Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry 2002; 159: 761-7.
40. Abi-Dargham A, Gil R, Krystal J et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 1998; 155: 761-7.
41. Laruelle M, Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmac 1999; 13: 358-71.
42. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 1999; 46: 56-72.
43. Kapur S, Roy P, Daskalakis J, Remington G, Zipursky R. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of halo-peridol to clozapine. Am J Psychiatry 2001; 158: 311-14.
44. Raskin S, Durst R, Katz G, Zislin J. Olanzapine and sulpiride: a preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia. J Clin Psychopharmac 2000; 20: 500-3.
45. Kapur S, Zipursky R, Jones C, Remington G, Houle, S. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am J Psychiatry 2000; 157: 514-20.
46. Okubo Y, Suhara T, Suzuki K et al. Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography. Life Sci 2000; 66: 2455-64.
47. Ngan ET, Yatham LN, Ruth TJ, Liddle PF. Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: a PET study using [(18)F]setoperone. Am J Psychiatry 2000; 157: 1016-18.
48. Busatto GF, Pilowsky LS, Costa DC et al. Correlation between reduced in vivo benzo-diazepine receptor binding and severity of psychotic symptoms in schizophrenia. Am J Psychiatry 1997; 154: 56-63.
49. Abi-Dargham A, Laruelle M, Krystal J et al. No evidnece of altered in vivo benzo-diazepine receptor binding in schizophrenia. Neuropsychopharmacology 1999; 20: 650-61.
50. Ball S, Busatto GF, David AS et al. Cognitive functioning and GABAA/benzo-diazepine receptor binding in schizophrenia: a 123I-iomazenil SPET study. Biol Psychiatry 1998; 43: 107-17.
51. Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann’s areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Am J Psychiatry 2001; 158: 918-25.
52. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 2000; 157: 1141-9.
53. Ibrahim HM, Hogg AJ, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry 2000; 157: 1811-23.
54. Meador-Woodruff JH, Davis KL, Haroutunian V. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology 2001; 24: 545-52.
55. Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986; 43: 114-24.
56. Berman KF, Ostrem JL, Randolph C et al. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia 1995; 33: 1027-46.
57. Volz HP, Gaser C, Hager F et al. Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test - a functional MRI study on healthy volunteers and schizophrenics. Psychiatry Res 1997; 75: 145-57.
58. Andreasen NC, Rezai K, Alliger R et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992; 49: 943-58.
59. Frith CD, Friston KJ, Herold S et al. Regional brain activity in chronic schizophrenic patients during the performance of a verbal working memory task. Br J Psychiatry 1995; 167: 343-9.
60. Dolan RJ, Fletcher PC, Frith CD, Friston KJ, Frackowiak RSJ, Grasby PM. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature 1995; 378: 180-2.
61. Yurgelun Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshaw PF. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 1996; 153: 200-5.
62. Callicott JH, Ramsey NF, Tallent K et al. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998; 18: 186-96.
63. Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD. Anterior cingulate cortex, error detection, and the online monitoring of performance. 1998; 280: 747-9.
64. Curtis VA, Bullmore ET, Brammer MJ et al. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 1998; 155: 1056-63.
65. Menon V, Anagnoson RT, Mathalon DH, Glover GH, Pfefferbaum A. Functional neuroanatomy of auditory working memory in schizophrenia: relation to positive and negative symptoms. Neuroimage 2001; 13: 433-46.
66. Heckers S, Rauch SL, Goff D et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nature Neurosci 1998; 1: 318-23.
67. Fletcher PC, McKenna PJ, Frith CD, Grasby PM, Friston KJ, Dolan RJ. Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging. Arch Gen Psychiatry 1998; 55: 1001-8.
68. Manoach DS, Gollub RL, Benson ES et al. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000; 48: 99-109.
69. Cohen RM, Nordahl TE, Semple WE, Andreason P, Pickar D. Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia. Neuropsychopharmacology 1998; 19: 36-47.
70. Fallgatter AJ, Strik WK. Reduced frontal functional asymmetry in schizophrenia during a cued continuous performance test assessed with near-infrared spectroscopy. Schizophrenia Bull 2000; 26: 913-19.
71. Yucel M, Pantelis C, Stuart GW et al. Anterior cingulate activation during Stroop task performance: a PET to MRI coregistration study of individual patients with schizophrenia. Am J Psychiatry 2002; 159: 251-4.
72. Menon RR, Barta PE, Aylward EH et al. Posterior superior temporal gyrus in schizophrenia: grey matter changes and clinical correlates. Schizophrenia Res 1995; 16: 127-35.
73. McGuire PK, Quested DJ, Spence SA, Murray RM, Frith CD, Liddle PF. Pathophysiology of ‘positive’ thought disorder in schizophrenia. Br J Psychiatry 1998; 173: 231-5.
74. Shenton ME, Kikinis R, Jolesz FA et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med 1992; 327: 604-12.
75. Zorrilla LTE, Jeste DV, Brown GG. Functional MRI and novel picture-learning among older patients with chronic schizophrenia: abnormal correlations between recognition memory and medial temporal brain response. Am J Geriatr Psychiatry 2002; 10: 52-61.
76. Bentall R. Deconstructing the concept of schizophrenia. J Ment Health 1993; 2: 223-38.
77. Bentall RP, Jackson HF, Pilgrim D. Abandoning the concept of ‘schizophrenia’: some implications of validity arguments psychological research into psychotic phenomena. Br J Clin Psychol 1988; 27: 303-24.
78. Bentall RP, Jackson HF, Pilgrim D. The concept of schizophrenia is dead: long live the concept of schizophrenia? Br J Clin Psychol 1988; 27: 329-31.
79. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 1998; 155: 1285-7.
80. Ganguli R, Carter C, Mintun M et al. PET brain mapping study of auditory verbal supraspan memory versus visual fixation in schizophrenia. Biol Psychiatry 1997; 41: 33-42.
81. Liddle PF, Friston KJ, Frith CD, Frackowiak RS. Cerebral blood flow and mental processes in schizophrenia. J Roy Soc Med 1992; 85: 224-7.
82. Kaplan RD, Szechtman H, Franco S et al. Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET). Schizophrenia Res 1993; 11: 47-54.
83. Cleghorn JM, Franco S, Szechtman B et al. Toward a brain map of auditory hallucinations. Am J Psychiatry 1992; 149: 1062-9.
84. McGuire PK, Shah GM, Murray RM. Increased blood flow in Broca’s area during auditory hallucinations in schizophrenia. Lancet 1993; 342: 703-6.
85. Silbersweig DA, Stern E, Frith C et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995; 378: 176-9.
86. Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 2000; 57: 1033-8.
87. Blackwood NJ, Howard RJ, Ffytche DH, Simmons A, Bentall RP, Murray RM. Imaging attentional and attributional bias: an fMRI approach to the paranoid delusion. Psychol Med 2000; 30: 873-83.
88. Spence SA, Brooks DJ, Hirsch SR, Liddle PF, Meehan J, Grasby PM. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain 1997; 120: 1997-2011.
89. Baare WF, Pol HE, Boomsma DI et al. Quantitative genetic modeling of variation in human brain morphology. Cereb Cortex 2001; 11: 816-24.
90. Egan MF, Goldberg TE, Kolachana BS et al. Effect of COMT Val108/158 Met geno-type on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-22.
91. Weinberger DR, Egan MF, Bertolino A et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001; 50: 825-44.
92. Uttal WR. The New Phrenology: The Limits of Localizing Cognitive Processes in the Brain. (MIT Press: Cambridge, MA, 2001.)
93. Dye SM, Spence SA, Bench CJ et al. No evidence for left superior temporal dys-function in asymptomatic schizophrenia and bipolar disorder. PET study of verbal fluency. Br J Psychiatry 1999; 175: 367-74.
94. Spence SA, Hirsch SR, Brooks DJ, Grasby PM. Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of ‘hypofrontality’ with recovery from acute schizophrenia. Br J Psychiatry 1998; 172: 316-23.
95. Friston K, Frith CD. Schizophrenia: a disconnection syndrome? Clin Neurosci 1995; 3: 89-97.
96. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol 1992; 49: 401-6.
97. Allen RM, Young SJ. Phencyclidine-induced psychosis. Am J Psychiatry 1978; 135: 1081-4.
98. Cohen JD, Servan Schreiber D. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev 1992; 99: 45-77.
99. Hoffman RE, McGlashan TH. Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophrenia Bull 1993; 19: 119-40.
100. Haracz JL. Neural plasticity in schizophrenia. Schizophrenia Bull 1985; 11: 191-229.
101. Bleuler E. Dementia Praecox or the Group of Schizophrenias [English Translation]. (International Universities Press: New York, 1961.)
102. Frith CD. The Cognitive Neuropsychology of Schizophrenia. (Lawrence Earlbaum Associates: Hove, Sussex, 1992.)
103. Mcintosh AR, Gonzales-Lima F. Structural equation modelling and its application to network analysis in functional brain imaging. Hum Brain Mapping 1994; 2: 2-22.
104. Spence SA, Liddle PF, Stefan MD et al. Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised. Br J Psychiatry 2000; 176: 52-60.
105. Friston KJ, Frith CD, Frackowiak RSJ. Time-dependent changes in effective connectivity measured with PET. Hum Brain Mapping 1993; 1: 69-79.
106. McIntosh AR, Grady CL, Haxby JV, Ungerleider LG, Horwitz B. Changes in limbic and prefrontal functional interactions in a working memory task for faces. Cereb Cortex 1996; 6: 571-84.
107. Buchel C, Friston KJ. Dynamic changes in effective connectivity characterized by variable parameter regression and Kalman filtering. Hum Brain Mapp 1998; 6: 403-8.
108. Fletcher PC, Buchel C, Josephs O, Friston KJ, Dolan RJ. Learning-related neuronal responses in prefrontal cortex studied with functional neuroimaging. Cereb Cortex 1999; 9: 168-78.
109. Andreasen NC, Nopoulos P, O’Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 1999; 46: 908-20.
110. Andreasen NC, Arndt S, Swayze 2nd, V et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266: 294-8.
111. Stephan KE, Magnotta VA, White T et al. Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task. Psychol Med 2001; 31: 1065-78.
112. Fletcher PC, Frith CD, Grasby PM, Friston KJ, Dolan RJ. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci 1996; 16: 7055-62.
113. Meyer Lindenberg A, Poline JB, Kohn PD et al. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry 2001; 158: 1809-17.
114. Fletcher PC, McKenna PJ, Friston KJ, Frith CD, Dolan RJ. Abnormal cingulate modulation of fronto-temporal connectivity in schizophrenia. Neuroimage 1999; 9: 337-42.